A novel hypothesis for atherosclerosis as a cholesterol sulfate deficiency syndrome

Stephanie Seneff1, Robert M Davidson2, Ann Lauritzen3

  • 1Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge, MA, 02139, USA. Seneff@csail.mit.edu.

Insights

Atherosclerosis may stem from cholesterol sulfate deficiency, impacting vascular health and leading to plaque buildup. Increasing sulfur intake may be key to preventing cardiovascular disease and improving blood flow.

Area of Science:

  • Biochemistry
  • Cardiovascular Science
  • Water Physics

Background:

  • Atherosclerosis and ischemia/reperfusion injuries remain poorly understood.
  • Current treatments for myocardial infarction risk factors are often counterproductive.
  • The roles of cholesterol, sulfate, homocysteine, and inflammation in vascular disease require clarification.

Purpose of the Study:

  • To investigate a novel pathology of atherosclerosis.
  • To explain the accumulation of cholesterol and sulfate in atheromatous plaques.
  • To elucidate the mechanisms behind treatment resistance in cardiovascular disease.

Main Methods:

  • Literature search on atherosclerotic cardiovascular disease, properties of water, biosulfates, and electromagnetic fields.
  • Analysis of existing data to propose a new etiological theory.
  • Review of biochemical and biophysical principles governing vascular function.

Main Results:

  • Atherosclerosis is proposed to result from cholesterol sulfate deficiency.
  • Atheromatous plaques store cholesterol and sulfate, deriving sulfate from homocysteine.
  • Sulfate is crucial for structured water, endothelial health, and erythrocyte mobility; depletion causes cholesterol accumulation.
  • Low zeta potential due to sulfate depletion contributes to hypertension and thrombosis.
  • Streaming potential induces nitric oxide release, affecting extracellular matrix and sulfate distribution.

Conclusions:

  • A novel theory posits cholesterol sulfate deficiency as the primary cause of atherosclerosis.
  • Recommendations include high intake of sulfur-containing foods and avoidance of sulfate-depleting toxicants.
  • This interpretation could significantly alter atherosclerosis treatment strategies.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.1K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
779
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
602
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
783
Inflammation01:38

Inflammation

Overview
65.2K